Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of fugliglitinate benzoate versus placebo and alogliptin in type 2 diabetes mellitus
ChiCTR2000034343Phase 3Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fotagliptin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: HbA1c. Started Sep 2019; status: recruiting.
02
Drugs
fotagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000034343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034343.